Clive A. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Clive A. Smith has a total of 116 co-authors. Here are the top co-authors by number of shared publications:
- Stéphane Pintat
Department of Chemistry, University of Leicester, University Road, Leicester, UK
6 shared publications - Jonathan M. Percy
Department of Chemistry, University of Leicester, University Road, Leicester, UK
5 shared publications - Graeme Whyte
Cavendish Laboratory, Department of Physics, University of Cambridge, J.J. Thomson Ave, Cambridge CB3 0HE, UK
4 shared publications John Fawcett
Department of Chemistry, University of Leicester, University RoadUK
4 shared publicationsXin Li
Sphere Fluidics Limited, McClintock Building, Suite 7, Granta Park, Great Abington, Cambridge CB21 6GP, United Kingdom
4 shared publicationsBruno Bellina
Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, Manchester M1 7DN, United Kingdom
3 shared publications
Latest Publications
- 15 February 2024
- Published by Wiley in European Journal of Haematology
- Vol. 112 (3)
Featured Cover
- Open Access
- 7 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Assembly of Droplet Reinjection-MS Interfaces: Overcoming Droplet Coalescence for High Throughput Screening Applications.
Droplet microfluidics coupled with mass spectrometry is evolving for high throughput screening. A commercial solution that can readily interface to existing mass spectrometry instrumentation would be highly desirable and allow the technology to become accessible to those without experience in droplet microfluidics. Here, we demonstrate a droplet reinjection workflow to infuse samples into three common mass spectrometers, each with different electrospray ionisation (ESI) source configurations. The ease of chip-mass spectrometry (MS) coupling is explored and difficulties highlighted. Particular attention has been turned to ESI sources which apply the electrospray voltage directly to the incoming droplet emitter (‘push source’), as these were found to cause droplet coalescence within the microfluidic chip reinjection channel. To overcome such a difficulty, we have identified different solutions including a grounded mesh insert as a shielding approach, and minor changes to chips and ESI sources to stabilise incoming droplets. Results obtained allow the mass spectrum of individual reinjected droplets to be determined without hindrance from the electrospray voltage. The problems and solutions identified here, outline the foundations for the development of a commercial droplet reinjection-mass spectrometry interface.
- 7 February 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAssembly of Droplet Reinjection-MS Interfaces: Overcoming Droplet Coalescence for High Throughput Screening Applications.
Droplet microfluidics coupled with mass spectrometry is evolving for high throughput screening. A commercial solution that can readily interface to existing mass spectrometry instrumentation would be highly desirable and allow the technology to become accessible to those without experience in droplet microfluidics. Here, we demonstrate a droplet reinjection workflow to infuse samples into three common mass spectrometers, each with different electrospray ionisation (ESI) source configurations. The ease of chip-mass spectrometry (MS) coupling is explored and difficulties highlighted. Particular attention has been turned to ESI sources which apply the electrospray voltage directly to the incoming droplet emitter (‘push source’), as these were found to cause droplet coalescence within the microfluidic chip reinjection channel. To overcome such a difficulty, we have identified different solutions including a grounded mesh insert as a shielding approach, and minor changes to chips and ESI sources to stabilise incoming droplets. Results obtained allow the mass spectrum of individual reinjected droplets to be determined without hindrance from the electrospray voltage. The problems and solutions identified here, outline the foundations for the development of a commercial droplet reinjection-mass spectrometry interface.
- Open Access
- 22 December 2023
- Published by MDPI AG in Micromachines
- Vol. 15 (1) , 27
Image-Based Feedback of Multi-Component Microdroplets for Ultra-Monodispersed Library Preparation
Using devices with microfluidic channels can allow for precise control over liquids flowing through them. Merging flows of immiscible liquids can create emulsions with highly monodispersed microdroplets within a carrier liquid, which are ideal for miniaturised reaction vessels which can be generated with a high throughput of tens of thousands of droplets per second. Control of the size and composition of these droplets is generally performed by controlling the pumping system pushing the liquids into the device; however, this is an indirect manipulation and inadequate if absolute precision is required in the size or composition of the droplets. In this work, we extend the previous development of image-based closed-loop feedback control over microdroplet generation to allow for the control of not only the size of droplets but also the composition by merging two aqueous flows. The feedback allows direct control over the desired parameters of volume and ratio of the two components over a wide range of ratios and outperforms current techniques in terms of monodispersity in volume and composition. This technique is ideal for situations where precise control over droplets is critical, or where a library of droplets of different concentrations but the same volume is required.
- 22 December 2023
- Published by MDPI AG in Micromachines
- Vol. 15 (1) , 27
Open AccessImage-Based Feedback of Multi-Component Microdroplets for Ultra-Monodispersed Library Preparation
Using devices with microfluidic channels can allow for precise control over liquids flowing through them. Merging flows of immiscible liquids can create emulsions with highly monodispersed microdroplets within a carrier liquid, which are ideal for miniaturised reaction vessels which can be generated with a high throughput of tens of thousands of droplets per second. Control of the size and composition of these droplets is generally performed by controlling the pumping system pushing the liquids into the device; however, this is an indirect manipulation and inadequate if absolute precision is required in the size or composition of the droplets. In this work, we extend the previous development of image-based closed-loop feedback control over microdroplet generation to allow for the control of not only the size of droplets but also the composition by merging two aqueous flows. The feedback allows direct control over the desired parameters of volume and ratio of the two components over a wide range of ratios and outperforms current techniques in terms of monodispersity in volume and composition. This technique is ideal for situations where precise control over droplets is critical, or where a library of droplets of different concentrations but the same volume is required.
- Open Access
- 11 December 2023
- Published by Wiley in European Journal of Haematology
- Vol. 112 (3) , 339-349
The current challenges faced by people with hemophilia B
Hemophilia B (HB) is a rare, hereditary disease caused by a defect in the gene encoding factor IX (FIX) and leads to varying degrees of coagulation deficiency. The prevailing treatment for people with HB (PWHB) is FIX replacement product. The advent of recombinant coagulation products ushered in a new era of safety, efficacy, and improved availability compared with plasma‐derived products. For people with severe HB, lifelong prophylaxis with a FIX replacement product is standard of care. Development of extended half‐life FIX replacement products has allowed for advancements in the care of these PWHB. Nonetheless, lifelong need for periodic dosing and complex surveillance protocols pose substantive challenges in terms of access, adherence, and healthcare resource utilization. Further, some PWHB on prophylactic regimens continue to experience breakthrough bleeds and joint damage, and subpopulations of PWHB, including women, those with mild‐to‐moderate HB, and those with inhibitors to FIX, experience additional unique difficulties. This review summarizes the current challenges faced by PWHB, including the unique subpopulations; identifying the need for improved awareness, personalized care strategies, and new therapeutic options for severe HB, which may provide future solutions for some of the remaining unmet needs of PWHB.
- 11 December 2023
- Published by Wiley in European Journal of Haematology
- Vol. 112 (3) , 339-349
Open AccessThe current challenges faced by people with hemophilia B
Hemophilia B (HB) is a rare, hereditary disease caused by a defect in the gene encoding factor IX (FIX) and leads to varying degrees of coagulation deficiency. The prevailing treatment for people with HB (PWHB) is FIX replacement product. The advent of recombinant coagulation products ushered in a new era of safety, efficacy, and improved availability compared with plasma‐derived products. For people with severe HB, lifelong prophylaxis with a FIX replacement product is standard of care. Development of extended half‐life FIX replacement products has allowed for advancements in the care of these PWHB. Nonetheless, lifelong need for periodic dosing and complex surveillance protocols pose substantive challenges in terms of access, adherence, and healthcare resource utilization. Further, some PWHB on prophylactic regimens continue to experience breakthrough bleeds and joint damage, and subpopulations of PWHB, including women, those with mild‐to‐moderate HB, and those with inhibitors to FIX, experience additional unique difficulties. This review summarizes the current challenges faced by PWHB, including the unique subpopulations; identifying the need for improved awareness, personalized care strategies, and new therapeutic options for severe HB, which may provide future solutions for some of the remaining unmet needs of PWHB.
- Open Access
- 11 November 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (11) , 2330
Microfluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new cases and 1.5 million deaths in 2020. TB is caused by infection with the major human pathogen Mycobacterium tuberculosis, which is difficult to rapidly diagnose and treat. There is an urgent need for new methods of diagnosis, sufficient in vitro models that capably mimic all physiological conditions of the infection, and high-throughput drug screening platforms. Microfluidic-based techniques provide single-cell analysis which reduces experimental time and the cost of reagents, and have been extremely useful for gaining insight into monitoring microorganisms. This review outlines the field of microfluidics and discusses the use of this novel technique so far in M. tuberculosis diagnostics, research methods, and drug discovery platforms. The practices of microfluidics have promising future applications for diagnosing and treating TB.
- 11 November 2021
- Published by MDPI AG in Microorganisms
- Vol. 9 (11) , 2330
Open AccessMicrofluidics as a Novel Technique for Tuberculosis: From Diagnostics to Drug Discovery
Tuberculosis (TB) remains a global healthcare crisis, with an estimated 5.8 million new cases and 1.5 million deaths in 2020. TB is caused by infection with the major human pathogen Mycobacterium tuberculosis, which is difficult to rapidly diagnose and treat. There is an urgent need for new methods of diagnosis, sufficient in vitro models that capably mimic all physiological conditions of the infection, and high-throughput drug screening platforms. Microfluidic-based techniques provide single-cell analysis which reduces experimental time and the cost of reagents, and have been extremely useful for gaining insight into monitoring microorganisms. This review outlines the field of microfluidics and discusses the use of this novel technique so far in M. tuberculosis diagnostics, research methods, and drug discovery platforms. The practices of microfluidics have promising future applications for diagnosing and treating TB.
- Open Access
- 30 July 2020
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (18) , 12605-12612
Coupling Droplet Microfluidics with Mass Spectrometry for Ultrahigh-Throughput Analysis of Complex Mixtures up to and above 30 Hz
- 30 July 2020
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (18) , 12605-12612
Open AccessCoupling Droplet Microfluidics with Mass Spectrometry for Ultrahigh-Throughput Analysis of Complex Mixtures up to and above 30 Hz
- Open Access
- 22 June 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Coupling Droplet Microfluidics with Mass Spectrometry for Ultrahigh-Throughput Analysis up to and Above 30Hz.
High and ultra-high-throughput label-free sample analysis is required by many applications, extending from environ-mental monitoring to drug discovery and industrial biotechnology. HTS methods predominantly are based on a targeted workflow, which can limit their scope. Mass spectrometry readily provides chemical identity and abundance for complex mixtures and here, we use microdroplet generation microfluidics to supply picolitre aliquots for analysis at rates up to and including 33 Hz. This is demon-strated for small molecules, peptides and proteins up to 66 kDa on three commercially available mass spectrometers from salty solutions to mimic cellular environments. Designs for chip-based interfaces that permit this coupling are presented and the merits and challenges of these interfaces are discussed. On an Orbitrap platform droplet infusion rates of 6 Hz are used for the analysis of cytochrome c, on a DTIMS Q-TOF similar rates were obtained and on a TWIMS Q-TOF utilizing IM-MS software rates up to 33 Hz are demonstrated. The potential of this approach is demonstrated with proof of concept experiments on crude mixtures including egg white, unpurified recombinant protein and a biotransformation supernatant.
- 22 June 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCoupling Droplet Microfluidics with Mass Spectrometry for Ultrahigh-Throughput Analysis up to and Above 30Hz.
High and ultra-high-throughput label-free sample analysis is required by many applications, extending from environ-mental monitoring to drug discovery and industrial biotechnology. HTS methods predominantly are based on a targeted workflow, which can limit their scope. Mass spectrometry readily provides chemical identity and abundance for complex mixtures and here, we use microdroplet generation microfluidics to supply picolitre aliquots for analysis at rates up to and including 33 Hz. This is demon-strated for small molecules, peptides and proteins up to 66 kDa on three commercially available mass spectrometers from salty solutions to mimic cellular environments. Designs for chip-based interfaces that permit this coupling are presented and the merits and challenges of these interfaces are discussed. On an Orbitrap platform droplet infusion rates of 6 Hz are used for the analysis of cytochrome c, on a DTIMS Q-TOF similar rates were obtained and on a TWIMS Q-TOF utilizing IM-MS software rates up to 33 Hz are demonstrated. The potential of this approach is demonstrated with proof of concept experiments on crude mixtures including egg white, unpurified recombinant protein and a biotransformation supernatant.
- Open Access
- 11 February 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Coupling Droplet Microfluidics with Mass Spectrometry for Ultrahigh-Throughput Analysis up to and Above 30Hz.
Here we use microdroplet generation microfluidics to supply picolitre aliquots of analyte for mass spectrometry analysis at rates up to and including 33 Hz. This is demonstrated for peptides and proteins on three commercially available mass spectrometers from salty solutions. Designs for chip-based interfaces that permit this coupling are presented and the merits and challenges of these interfaces are discussed. On an Orbitrap platform droplet infusion rates of 6 Hz are used for the analysis of cytochrome c, on a DTIMS Q-TOF similar rates were obtained and on a TWIMS Q-TOF utilizing IM-MS software rates up to 33 Hz are demonstrated for both peptides and proteins at concentrations down to 400 pg per aliquot.
- 11 February 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCoupling Droplet Microfluidics with Mass Spectrometry for Ultrahigh-Throughput Analysis up to and Above 30Hz.
Here we use microdroplet generation microfluidics to supply picolitre aliquots of analyte for mass spectrometry analysis at rates up to and including 33 Hz. This is demonstrated for peptides and proteins on three commercially available mass spectrometers from salty solutions. Designs for chip-based interfaces that permit this coupling are presented and the merits and challenges of these interfaces are discussed. On an Orbitrap platform droplet infusion rates of 6 Hz are used for the analysis of cytochrome c, on a DTIMS Q-TOF similar rates were obtained and on a TWIMS Q-TOF utilizing IM-MS software rates up to 33 Hz are demonstrated for both peptides and proteins at concentrations down to 400 pg per aliquot.
- 10 December 2018
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (3) , 872-891
High throughput screening of complex biological samples with mass spectrometry – from bulk measurements to single cell analysis
We review the state of the art in HTS using mass spectrometry with minimal sample preparation from complex biological matrices. We focus on industrial and biotechnological applications.
- 10 December 2018
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 144 (3) , 872-891
High throughput screening of complex biological samples with mass spectrometry – from bulk measurements to single cell analysis
We review the state of the art in HTS using mass spectrometry with minimal sample preparation from complex biological matrices. We focus on industrial and biotechnological applications.
- Open Access
- 5 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-9
Image-based closed-loop feedback for highly mono-dispersed microdroplet production
Micron-scale droplets isolated by an immiscible liquid can provide miniaturised reaction vessels which can be manipulated in microfluidic networks, and has seen a rapid growth in development. In many experiments, the precise volume of these microdroplets is a critical parameter which can be influenced by many external factors. In this work, we demonstrate the combination of imaging-based feedback and pressure driven pumping to accurately control the size of microdroplets produced in a microfluidic device. The use of fast-response, pressure-driving pumps allows the microfluidic flow to be quickly and accurately changed, while directly measuring the droplet size allows the user to define the more meaningful parameters of droplet size and generation frequency rather than flow rates or pressures. The feedback loop enables the drift correction of pressure based pumps, and leads to a large increase in the mono-dispersity of the droplets produced over long periods. We also show how this can be extended to control multiple liquid flows, allowing the frequency of droplet formation or the average concentration of living cells per droplet to be controlled and kept constant.
- 5 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-9
Open AccessImage-based closed-loop feedback for highly mono-dispersed microdroplet production
Micron-scale droplets isolated by an immiscible liquid can provide miniaturised reaction vessels which can be manipulated in microfluidic networks, and has seen a rapid growth in development. In many experiments, the precise volume of these microdroplets is a critical parameter which can be influenced by many external factors. In this work, we demonstrate the combination of imaging-based feedback and pressure driven pumping to accurately control the size of microdroplets produced in a microfluidic device. The use of fast-response, pressure-driving pumps allows the microfluidic flow to be quickly and accurately changed, while directly measuring the droplet size allows the user to define the more meaningful parameters of droplet size and generation frequency rather than flow rates or pressures. The feedback loop enables the drift correction of pressure based pumps, and leads to a large increase in the mono-dispersity of the droplets produced over long periods. We also show how this can be extended to control multiple liquid flows, allowing the frequency of droplet formation or the average concentration of living cells per droplet to be controlled and kept constant.